Works matching AU Goettsch, Wim G.

Results: 41

Evolving Recommendations for Patient Populations Among Oncology Medicines: A Quantitative and Qualitative Analysis.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 118, n. 1, p. 95, doi. 10.1002/cpt.3628

By:

Hogervorst, Milou A.;
Vreman, Rick A.;
Oduol, Theresa A.;
Mantel‐Teeuwisse, Aukje K.;
Goettsch, Wim G.;
Kesselheim, Aaron S.

Publication type:

Article

Information Patients With Melanoma Spontaneously Report About Health-Related Quality of Life on Web-Based Forums: Case Study.

Published in:

2021

By:

Kalf, Rachel R J;
Delnoij, Diana M J;
Ryll, Bettina;
Bouvy, Marcel L;
Goettsch, Wim G

Publication type:

journal article

Adherence to evidence-based statin guidelines reduces the risk of hospitalizations for acute myocardial infarction by 40%: a cohort study.

Published in:

European Heart Journal, 2007, v. 28, n. 2, p. 154

By:

Penning-van Beest, Fernie J.A.;
Termorshuizen, Fabian;
Goettsch, Wim G.;
Klungel, Olaf H.;
Kastelein, John J.P.;
Herings, Ron M.C.

Publication type:

Article

The Cost-Effectiveness of an Intensive Treatment Protocol for Severe Dyslexia in Children.

Published in:

Dyslexia (10769242), 2011, v. 17, n. 3, p. 256, doi. 10.1002/dys.436

By:

Hakkaart-van Roijen, Leona;
Goettsch, Wim G.;
Ekkebus, Michel;
Gerretsen, Patty;
Stolk, Elly A.

Publication type:

Article

Disease severity-based subgrouping of type 2 diabetes does not parallel differences in quality of life: the Maastricht Study.

Published in:

Diabetologia, 2024, v. 67, n. 4, p. 690, doi. 10.1007/s00125-023-06082-4

By:

Werkman, Nikki C. C.;
García-Sáez, Gema;
Nielen, Johannes T. H.;
Tapia-Galisteo, Jose;
Somolinos-Simón, Francisco J.;
Hernando, Maria E.;
Wang, Junfeng;
Jiu, Li;
Goettsch, Wim G.;
van der Kallen, Carla J. H.;
Koster, Annemarie;
Schalkwijk, Casper G.;
de Vries, Hein;
de Vries, Nanne K.;
Eussen, Simone J. P. M.;
Driessen, Johanna H. M.;
Stehouwer, Coen D. A.

Publication type:

Article

Managed Entry Agreements for High-Cost, One-Off Potentially Curative Therapies: A Framework and Calculation Tool to Determine Their Suitability: Framework and Calculation Tool to Determine the Suitability of MEAs: M.H.E. Callenbach et al.

Published in:

PharmacoEconomics, 2025, v. 43, n. 1, p. 53, doi. 10.1007/s40273-024-01433-4

By:

Callenbach, Marcelien H. E.;
Vreman, Rick A.;
Leopold, Christine;
Mantel-Teeuwisse, Aukje K.;
Goettsch, Wim G.

Publication type:

Article

Comment on "Deterministic Sensitivity Analysis Under Ignorance".

Published in:

2021

By:

Vreman, Rick A.;
Geenen, Joost W;
Knies, Saskia;
Mantel-Teeuwisse, Aukje K.;
Leufkens, Hubert G. M.;
Goettsch, Wim G.

Publication type:

Letter

The Application and Implications of Novel Deterministic Sensitivity Analysis Methods.

Published in:

PharmacoEconomics, 2021, v. 39, n. 1, p. 1, doi. 10.1007/s40273-020-00979-3

By:

Vreman, Rick A.;
Geenen, Joost W.;
Knies, Saskia;
Mantel-Teeuwisse, Aukje K.;
Leufkens, Hubert G. M.;
Goettsch, Wim G.

Publication type:

Article

Modified Delphi procedure-based expert consensus on endpoints for an international disease registry for Metachromatic Leukodystrophy: The European Metachromatic Leukodystrophy initiative (MLDi).

Published in:

2022

By:

Schoenmakers, Daphne H.;
Beerepoot, Shanice;
van den Berg, Sibren;
Adang, Laura;
Bley, Annette;
Boelens, Jaap-Jan;
Fumagalli, Francesca;
Goettsch, Wim G.;
Grønborg, Sabine;
Groeschel, Samuel;
van Hasselt, Peter M.;
Hollak, Carla E. M.;
Lindemans, Caroline;
Mochel, Fanny;
Mol, Peter G. M.;
Sevin, Caroline;
Zerem, Ayelet;
Schöls, Ludger;
Wolf, Nicole I.

Publication type:

journal article

In-hospital use of opioids increases rate of coded postoperative paralytic ileus.

Published in:

Pharmacoepidemiology & Drug Safety, 2007, v. 16, n. 6, p. 668, doi. 10.1002/pds.1338

By:

Goettsch, Wim G.;
Sukel, Myrthe P. P.;
van der Peet, Donald L.;
van Riemsdijk, Melanie M.;
Herings, Ron M. C.

Publication type:

Article

Developments of the incidence of osteoporosis in The Netherlands: a PHARMO study.

Published in:

Pharmacoepidemiology & Drug Safety, 2007, v. 16, n. 2, p. 166, doi. 10.1002/pds.1245

By:

Goettsch, Wim G.;
de Jong, Romy B.;
Kramarz, Piotr;
Herings, Ron M.C.

Publication type:

Article

Rosuvastatin safety: a comprehensive, international pharmacoepidemiology programme.

Published in:

Pharmacoepidemiology & Drug Safety, 2006, v. 15, n. 7, p. 454, doi. 10.1002/pds.1260

By:

Johansson, Saga;
Ming, Eileen E.;
Wallander, Mari-Ann;
Rodríguez, Luis A. García;
Herings, Ron M. C.;
Goettsch, Wim G.;
González-Pérez, Antonio;
McAfee, Andrew T.;
Walker, Alexander M.

Publication type:

Article

Treatment patterns and health care costs of mebeverine-treated IBS patients: a case-control study.

Published in:

Pharmacoepidemiology & Drug Safety, 2004, v. 13, n. 11, p. 803, doi. 10.1002/pds.997

By:

Goettsch, Wim G.;
van den Boom, Guido;
Breekveldt-Postma, Nancy S.;
Smout, André J. P. M.;
Herings, Ron M. C.

Publication type:

Article

The impact of quality-of-life data in relative effectiveness assessments of new anti-cancer drugs in European countries.

Published in:

2017

By:

Kleijnen, Sarah;
Leonardo Alves, Teresa;
Meijboom, Kim;
Lipska, Iga;
Boer, Anthonius;
Leufkens, Hubertus;
Goettsch, Wim;
De Boer, Anthonius;
Leufkens, Hubertus G;
Goettsch, Wim G

Publication type:

journal article

Challenges and Opportunities for Companies to Build HTA/Payer Perspectives Into Drug Development Through the Use of a Dynamic Target Product Profile.

Published in:

Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.948161

By:

Ting Wang;
McAuslane, Neil;
Goettsch, Wim G.;
Leufkens, Hubert G. M.;
De Bruin, Marie L.

Publication type:

Article

Decision Making Under Uncertainty: Comparing Regulatory and Health Technology Assessment Reviews of Medicines in the United States and Europe.

Published in:

Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 2, p. 350, doi. 10.1002/cpt.1835

By:

Vreman, Rick A.;
Naci, Huseyin;
Goettsch, Wim G.;
Mantel‐Teeuwisse, Aukje K.;
Schneeweiss, Sebastian G.;
Leufkens, Hubert G. M.;
Kesselheim, Aaron S.

Publication type:

Article

Weighing of Evidence by Health Technology Assessment Bodies: Retrospective Study of Reimbursement Recommendations for Conditionally Approved Drugs.

Published in:

Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 3, p. 684, doi. 10.1002/cpt.1251

By:

Hövels, Anke M.;
Mantel‐Teeuwisse, Aukje K.;
Leufkens, Hubert G.M.;
Vreman, Rick A.;
Goettsch, Wim G.;
Bloem, Lourens T.;
Bouvy, Jacoline C.

Publication type:

Article

Real World Data in Health Technology Assessment of Complex Health Technologies.

Published in:

Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.837302

By:

Hogervorst, Milou A.;
Pontén, Johan;
Vreman, Rick A.;
Mantel-Teeuwisse, Aukje K.;
Goettsch, Wim G.

Publication type:

Article

Efficacy gap between phase II and subsequent phase III studies in oncology.

Published in:

British Journal of Clinical Pharmacology, 2020, v. 86, n. 7, p. 1306, doi. 10.1111/bcp.14237

By:

Vreman, Rick A.;
Belitser, Svetlana V.;
Mota, Ana T.M.;
Hövels, Anke M.;
Goettsch, Wim G.;
Roes, Kit C.B.;
Leufkens, Hubert G.M.;
Mantel‐Teeuwisse, Aukje K.

Publication type:

Article

Inappropriate initial treatment of secondary intra-abdominal infections leads to increased risk of clinical failure and costs.

Published in:

British Journal of Clinical Pharmacology, 2005, v. 60, n. 4, p. 438, doi. 10.1111/j.1365-2125.2005.02443.x

By:

Sturkenboom, Miriam C. J. M.;
Goettsch, Wim G.;
Picelli, Gino;
in 't Veld, Bas;
Yin, Don D.;
de Jong, Romy B.;
Go, Peter M. N. Y. H.;
Herings, Ron M. C.

Publication type:

Article

Increased treatment failure after 3-days’ courses of nitrofurantoin and trimethoprim for urinary tract infections in women: a population-based retrospective cohort study using the PHARMO database.

Published in:

British Journal of Clinical Pharmacology, 2004, v. 58, n. 2, p. 184, doi. 10.1111/j.1365-2125.2004.02106.x

By:

Goettsch, Wim G.;
Janknegt, Rob;
Herings, Ron M.C.

Publication type:

Article

When Reality Does Not Meet Expectations—Experiences and Perceived Attitudes of Dutch Stakeholders Regarding Payment and Reimbursement Models for High-Priced Hospital Drugs.

Published in:

International Journal of Environmental Research & Public Health, 2023, v. 20, n. 1, p. 340, doi. 10.3390/ijerph20010340

By:

Callenbach, Marcelien H. E.;
Vreman, Rick A.;
Mantel-Teeuwisse, Aukje K.;
Goettsch, Wim G.

Publication type:

Article

Application of Managed Entry Agreements for Innovative Therapies in Different Settings and Combinations: A Feasibility Analysis.

Published in:

International Journal of Environmental Research & Public Health, 2020, v. 17, n. 22, p. 8309, doi. 10.3390/ijerph17228309

By:

A Vreman, Rick;
F Broekhoff, Thomas;
GM Leufkens, Hubert;
K Mantel-Teeuwisse, Aukje;
G Goettsch, Wim

Publication type:

Article

The Role of Regulator-Imposed Post-Approval Studies in Health Technology Assessments for Conditionally Approved Drugs.

Published in:

International Journal of Health Policy & Management, 2022, v. 11, n. 5, p. 642, doi. 10.34172/ijhpm.2020.198

By:

Vreman, Rick A.;
Bloem, Lourens T.;
van Oirschot, Stijn;
Hoekman, Jarno;
van der Elst, Menno E.;
Leufkens, Hubert G. M.;
Klungel, Olaf H.;
Goettsch, Wim G.;
Mantel-Teeuwisse, Aukje K.

Publication type:

Article

The Costs of Benzodiazepine-Associated Hospital-Treated Fall Injuries in the EU: a Pharmo Study.

Published in:

Drugs & Aging, 2003, v. 20, n. 11, p. 833, doi. 10.2165/00002512-200320110-00004

By:

Panneman, Martien J. M.;
Goettsch, Wim G.;
Kramarz, Piotr;
Herings, Ron M. C.

Publication type:

Article

Synergy between health technology assessments and clinical guidelines for multiple sclerosis.

Published in:

CTS: Clinical & Translational Science, 2023, v. 16, n. 5, p. 835, doi. 10.1111/cts.13492

By:

Hogervorst, Milou A.;
Vreman, Rick A.;
Zawada, Anna;
Zielińska, Magdalena;
Dawoud, Dalia M.;
de Jong, Brigit A.;
Mantel‐Teeuwisse, Aukje K.;
Goettsch, Wim G.

Publication type:

Article

Associations between uncertainties identified by the European Medicines Agency and national decision making on reimbursement by HTA agencies.

Published in:

CTS: Clinical & Translational Science, 2021, v. 14, n. 4, p. 1566, doi. 10.1111/cts.13027

By:

Bloem, Lourens T.;
Vreman, Rick A.;
Peeters, Niels W. L.;
Hoekman, Jarno;
Elst, Menno E.;
Leufkens, Hubert G. M.;
Klungel, Olaf H.;
Goettsch, Wim G.;
Mantel‐Teeuwisse, Aukje K.

Publication type:

Article

Phase I/II Clinical Trial-Based Early Economic Evaluation of Acalabrutinib for Relapsed Chronic Lymphocytic Leukaemia.

Published in:

Applied Health Economics & Health Policy, 2019, v. 17, n. 6, p. 883, doi. 10.1007/s40258-019-00496-1

By:

Vreman, Rick A.;
Geenen, Joost W.;
Hövels, Anke M.;
Goettsch, Wim G.;
Leufkens, Hubert G. M.;
Al, Maiwenn J.

Publication type:

Article

Harmonizing HTA Evidence Needs and Expectations: Challenges and Opportunities to Improve Evidence Generation, Ensure Access and Affordability.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 938, doi. 10.1002/cpt.3579

By:

Emond, Sarah K.;
Goettsch, Wim G.;
Ollendorf, Daniel A.

Publication type:

Article

Regulatory, health technology assessment and company interactions: the current landscape and future ecosystem for drug development, review and reimbursement.

Published in:

International Journal of Technology Assessment in Health Care, 2023, v. 39, n. 1, p. 1, doi. 10.1017/S0266462323000144

By:

Ting Wang;
McAuslane, Neil;
Goettsch, Wim G.;
Leufkens, Hubert G. M.;
De Bruin, Marie L.

Publication type:

Article

PP146 The Use Of Indirect Comparisons For Reimbursement Decision Making In The Netherlands And England.

Published in:

2022

By:

Kalf, Rachel;
Dawoud, Dalia;
Bregman, Caroline;
Leckenby, Emily;
de Vries, Marijke J.S.;
Delnoij, Diana M.J.;
Bouvy, Marcel L.;
Goettsch, Wim G.

Publication type:

Abstract

Understanding innovation of health technology assessment methods: the IHTAM framework.

Published in:

International Journal of Technology Assessment in Health Care, 2022, v. 38, n. 1, p. 1, doi. 10.1017/S0266462322000010

By:

Jiu, Li;
Hogervorst, Milou A.;
Vreman, Rick A.;
Mantel-Teeuwisse, Aukje K.;
Goettsch, Wim G.

Publication type:

Article

Addressing uncertainty in relative effectiveness assessments by HTA organizations.

Published in:

International Journal of Technology Assessment in Health Care, 2022, v. 38, n. 1, p. 1, doi. 10.1017/S026646232100177X

By:

Vreman, Rick A.;
Strigkos, George;
Leufkens, Hubert G. M.;
Schünemann, Holger J.;
Mantel-Teeuwisse, Aukje K.;
Goettsch, Wim G.

Publication type:

Article

Bridging health technology assessment and healthcare quality improvement using international consortium of health outcomes measurement standard sets.

Published in:

2022

By:

Kalf, Rachel R. J.;
Zuidgeest, Marloes;
Delnoij, Diana M. J.;
Bouvy, Marcel L.;
Goettsch, Wim G.

Publication type:

journal article

Understanding innovation of health technology assessment methods: the IHTAM framework.

Published in:

International Journal of Technology Assessment in Health Care, 2021, v. 38, n. 1, p. 1, doi. 10.1017/S0266462322000010

By:

Jiu, Li;
Hogervorst, Milou A.;
Vreman, Rick A.;
Mantel-Teeuwisse, Aukje K.;
Goettsch, Wim G.

Publication type:

Article

Addressing uncertainty in relative effectiveness assessments by HTA organizations.

Published in:

International Journal of Technology Assessment in Health Care, 2021, v. 38, n. 1, p. 1, doi. 10.1017/S026646232100177X

By:

Vreman, Rick A.;
Strigkos, George;
Leufkens, Hubert G. M.;
Schünemann, Holger J.;
Mantel-Teeuwisse, Aukje K.;
Goettsch, Wim G.

Publication type:

Article

Exploring the opportunities for alignment of regulatory postauthorization requirements and data required for performance-based managed entry agreements.

Published in:

2021

By:

Eichler, Hans-Georg;
Adams, Roisin;
Andreassen, Einar;
Arlett, Peter;
van de Casteele, Marc;
Chapman, Suzannah J.;
Goettsch, Wim G.;
Martinsson, Jonathan Lind;
Llinares-Garcia, Jordi;
Nachtnebel, Anna;
Pean, Elias;
Rasi, Guido;
Reksten, Tove Ragna;
Timmers, Lonneke;
Vreman, Rick A.;
van de Vijver, Inneke;
Wenzl, Martin

Publication type:

journal article

Bridging health technology assessment and healthcare quality improvement using international consortium of health outcomes measurement standard sets.

Published in:

International Journal of Technology Assessment in Health Care, 2021, v. 38, n. 1, p. 1, doi. 10.1017/S0266462321000520

By:

Kalf, Rachel R. J.;
Zuidgeest, Marloes;
Delnoij, Diana M. J.;
Bouvy, Marcel L.;
Goettsch, Wim G.

Publication type:

Article

PILOTING INTERNATIONAL PRODUCTION OF RAPID RELATIVE EFFECTIVENESS ASSESSMENTS OF PHARMACEUTICALS.

Published in:

International Journal of Technology Assessment in Health Care, 2014, v. 30, n. 5, p. 521, doi. 10.1017/S0266462314000622

By:

Kleijnen, Sarah;
Pasternack, Iris;
Rannanheimo, Piia;
Vuola, Jenni M;
Van de Casteele, Marc;
Bucsics, Anna;
Pulis, Isabelle Zahra;
Di Bidino, Rossella;
Sacchini, Dario;
Montilla, Simona;
Abrishami, Payam;
Sammut, Sylvana Magrin;
Muscolo, Luisa Anna Adele;
Happonen, Pertti;
Goettsch, Wim G.

Publication type:

Article

STANDARDIZED REPORTING FOR RAPID RELATIVE EFFECTIVENESS ASSESSMENTS OF PHARMACEUTICALS.

Published in:

International Journal of Technology Assessment in Health Care, 2014, v. 30, n. 5, p. 488, doi. 10.1017/S0266462314000609

By:

Kleijnen, Sarah;
Pasternack, Iris;
Van de Casteele, Marc;
Rossi, Bernardette;
Cangini, Agnese;
Di Bidino, Rossella;
Jelenc, Marjetka;
Abrishami, Payam;
Autti-Rämö, Ilona;
Seyfried, Hans;
Wildbacher, Ingrid;
Goettsch, Wim G.

Publication type:

Article

Comparative effectiveness and safety of pharmaceuticals assessed in observational studies compared with randomized controlled trials.

Published in:

2021

By:

Hong, Yoon Duk;
Jansen, Jeroen P;
Guerino, John;
Berger, Marc L;
Crown, William;
Goettsch, Wim G;
Mullins, C Daniel;
Willke, Richard J;
Orsini, Lucinda S

Publication type:

journal article